e-Kare

What e-Kare does

eKare Inc. is a private medical technology company that builds AI-powered digital wound care solutions for healthcare providers and clinical research organizations. Its core product, inSight, is a CE-marked and FDA-registered 3D wound imaging device that uses computer vision to capture precise wound measurements without physical reference markers, enabling standardized documentation at the point of care. The platform is CE Mark certified, ISO 13485 compliant, HIPAA and GDPR aligned, and supports 21 CFR Part 11 workflows, making it usable across routine clinical care and regulated clinical trial environments. Additional products include healBot, a generative AI conversational assistant for wound care workflows, and eKare Gauss, an AI ecosystem that allows organizations to build custom models on eKare's imaging pipeline.

Underlying the product surface is a deep learning stack comprising Mask-R-CNN for pressure injury detection (reported 92.6% accuracy), hybrid DCN/DNN models for wound etiology classification (reported 94% accuracy), LSTM networks for healing trajectory prediction, and a proprietary training dataset of more than 100,000 wound images. The platform integrates with major clinical and research data systems including Epic, Cerner, and Medidata Rave, and is offered alongside telehealth, point-of-care assessment, and business intelligence modules.

The business model combines hardware sales (inSight imaging systems), SaaS subscriptions, professional services, and API/integration fees, sold primarily through direct enterprise field sales targeting hospitals, wound care centers, NHS Trusts, CROs, and medical device and pharmaceutical companies such as ConvaTec, KCI, and Novartis. The company is headquartered in Fairfax, Virginia, with a European subsidiary (eKare Europe BV) in the Netherlands and operational presence in the UK. The leadership team includes CEO Patrick Cheng and Dr. Paul Kim.

Name

e-Kare

Legal name

eKare Inc.

Website

https://ekare.ai

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

eKare Inc. develops AI-powered digital wound care solutions for healthcare providers and clinical research organizations. Its inSight platform uses computer vision for 3D wound measurement, augmented by healBot generative AI assistant and eKare Gauss AI ecosystem.

Ownership category

akta.pro rank

Product category

Digital Wound Care Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Wound Care & Ulcer Management (HLAKACAN)

Keywords

• Wound imaging software
• Digital wound assessment
• Clinical decision support
• Telehealth wound care
• Medical AI analytics

Headquarters

HQ city

Fairfax

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Software as a Service (SaaS) Platform: Subscription-based model for wound imaging and management platform access, including inSight software, telehealth services, and AI analytics tools.
2. Hardware Sales: Sale of inSight hardware systems including tablet computer, Structure Sensor, mounting bracket, connection cable, and power adapters. Hardware ownership remains with eKare unless otherwise agreed.
3. Professional Services: On-site training, implementation, and additional services beyond standard agreement scope, including custom integrations and support.
4. API and Integration Services: RESTful API access and pre-built integrations with EHR/EDC platforms including Epic, Cerner, and Medidata Rave for enterprise customers.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

e-Kare provides a digital wound care platform centered on its CE-marked and FDA-registered inSight 3D wound imaging and measurement device, which uses computer vision technology to capture wound dimensions without reference markers. The platform bundles AI-powered clinical decision support (healBot), telehealth and remote patient monitoring, point-of-care bedside documentation, and EHR-integrated analytics dashboards for hospitals, clinics, and clinical research organizations.

Product overview

eKare offers a unified digital wound care platform built around its core inSight product, a CE-marked and FDA-registered wound imaging and measurement device. The platform consists of multiple integrated modules: inSight (core imaging and documentation), healBot (generative AI assistant with Reference, Analytics, and Advisor components), eKare Gauss (AI ecosystem for custom model development), Telehealth Services (remote monitoring and video conferencing), Point of Care Assessment, Advanced Wound Imaging, Business Intelligence/Analytics, and Clinical Workflow Optimization. The products work together as a fully-integrated suite for wound assessment, wound documentation, eVisits, and remote patient monitoring.

Differentiator

Problem solved

Functional benefit

Brands

• inSight: CE-marked, FDA-registered wound measurement device for high quality imaging and assessment using computer vision technology
• healBot
• eKare Telehealth
• eKare Gauss
• eKloud

Products and services

• inSight CE-marked and FDA-registered wound measurement device using computer vision technology to capture high-quality 3D wound images and dimensions without reference markers, available on iPad with Structure Sensor and on iPhone with built-in optics for healthcare providers.
• healBot Generative AI conversational assistant for wound care comprising healBot Reference (clinical guidance), healBot Analytics (conversational analytics dashboard), and healBot Advisor (wound-level decision support), integrated within the inSight platform to deliver evidence-based guidance on clinical protocols, product qualification, and reimbursement pathways.
• eKare Gauss End-to-end AI ecosystem providing data labeling, automatic AI model selection, and cloud deployment, with access to eKare's data lake of over 100,000 images, measurements and 3D scans for healthcare AI teams building wound care applications.
• Telehealth Services HIPAA and GDPR compliant telehealth solution enabling virtual patient-provider engagements, real-time live video conferencing, store-and-forward data sharing, remote patient monitoring, and direct-to-patient or decentralized clinical trial workflows, with a patient app for wound image capture.
• Point of Care Assessment Mobile wound care documentation solution enabling clinicians to evaluate healing progression and document wounds at the patient's bedside, with automatic data capture, real-time imaging feedback, workflow alignment, and secure web portal access across multi-unit healthcare networks.
• Business Intelligence Dashboard Customizable and configurable real-time wound care analytics dashboard providing clinical decision support and practice management, with instant overview of time-critical metrics, key aspects of clinical studies, and operational performance for healthcare providers and research organizations.

Quantifiable outcome

• 92.6% accuracy in pressure injury detection
• +4 more outcomes

Named customers15 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability14 records

Feature8 records

Partnerships

Seven partnerships are on record, tiered core and major.

• NIH - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)coreStrategic or Co-development PartnerinSight wound management platform selected by NIDDK to support data collection and clinical monitoring for NIH-led Diabetic Foot Consortium national initiative for landmark diabetic foot ulcer research.
• NHS Digital Health Accelerator (East Midlands AHSN)coreStrategic or Co-development PartnerinSight digital 3D imaging and wound measurement system selected to join NHS Digital Health Accelerator designed to speed up technology adoption in NHS by providing support to develop and deploy solutions to pressing NHS challenges.
• Epic SystemscoreTechnology or IntegrationPre-built integration available through Epic App Orchard for seamless EHR connectivity. Epic is a registered trademark of Epic Systems Corporation.
• CernercoreTechnology or IntegrationPre-built integration with Cerner for clinical data management and wound documentation within Cerner EHR ecosystem.
• Medidata (Dassault Systèmes)coreTechnology or IntegrationIntegration with Medidata Rave EDC system for clinical trial wound assessment data capture and management.
• Oxford Health NHS Foundation TrustmajorStrategic or Co-development PartnerPartnership to demonstrate advanced digital wound management system within Oxford Health NHS Foundation Trust healthcare facilities.
• South Warwickshire NHS Foundation TrustmajorStrategic or Co-development PartnerImplementation partnership where SWFT uses inSight to maximize efficiency and save resources. SWFT recognized for digital excellence at HSJ Awards using eKare technology.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Swift Medical: Swift Medical provides AI-powered digital wound care imaging and management software for hospitals and post-acute providers, making it the closest direct competitor to eKare's inSight platform in clinical wound imaging.
• Aranz Medical: Aranz Medical's Silhouette system provides 3D wound measurement, imaging, and documentation for clinical and research use, comparable to eKare's inSight 3D wound assessment platform.
• MolecuLight: MolecuLight develops handheld fluorescence-based digital wound imaging devices that capture and quantify bacterial presence in wounds, competing directly with eKare's computer-vision wound measurement approach.
• WoundVision: WoundVision offers digital wound imaging and assessment tools combining thermal imaging and AI, overlapping with eKare's computer vision wound measurement and clinical decision support offering.
• Tissue Analytics (a Net Health company): Tissue Analytics offers an AI-powered wound imaging and analytics platform integrated with EHRs for hospitals and wound clinics, directly competing with eKare's wound measurement and documentation capabilities.

Emerging players

• Healthy.io: Healthy.io applies smartphone-based computer vision and AI to clinical assessments including wound and urinalysis imaging, sharing eKare's smartphone-first, AI-driven clinical imaging approach.
• Bruin Biometrics: Bruin Biometrics' SEM Scanner detects early-stage pressure injuries via sub-epidermal moisture sensing, an adjacent AI-enabled wound assessment technology serving similar hospital customers as eKare.

Broad incumbents

• Net Health: Net Health is a specialty EHR and analytics provider for wound care, rehab, and occupational health that now owns Tissue Analytics, directly competing with eKare in hospital and clinic wound documentation software.
• Smith & Nephew: Smith & Nephew is a large global wound care medtech incumbent selling dressings, NPWT, and increasingly digital wound management tools, making it both a potential partner and the dominant competitive threat to eKare.
• 3M Health Care (Solventum): 3M's Health Care business (now Solventum) is a major wound care and health IT player with the scale to bundle digital wound imaging into its broader portfolio, representing a significant competitive incumbent to eKare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ekare-inc-917348091693189
• YouTubeyoutube.com/channel/UCzH3y6HvGQZvT6CqPdK4rJw
• LinkedInlinkedin.com/company/ekare-inc-
• Xx.com/ekareinc

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about e-Kare